North America Pharmaceutical Excipients Market - Industry Trends and Forecast to 2029

North America pharmaceutical excipients market is projected to register a substantial CAGR of 6.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
North America Pharmaceutical Excipients Market, Functionality (Binders and Adhesives, Disintegrants, Coating Material, Disintegrants, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others) Geography (China, India, Japan, South Korea, Indonesia, Thailand, Vietnam, Philippines, Singapore, Malaysia, Australia, Rest of Asia Pacific)- Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the North America excipients market are:

• Innovations in biopharmaceuticals
• Increasing need for pharmaceutical products across varied therapeutic areas
Market Players:

The key market players operating in the North America Pharmaceutical Excipients market are listed below:
• DOW
• Roquette Frères
• JRS Pharma
• Evonik Industries AG
• The Lubrizol Corporation
• Kerry Group PLC
• Colorcon
• Ashland
• BASF SE